Prelude Therapeutics Incorporated
PRLD
$5.55
$0.193.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 151.76M | 81.55M | 103.21M | 54.96M | 73.22M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.14M | 3.04M | 2.48M | 3.37M | 3.66M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 154.90M | 84.59M | 105.69M | 58.33M | 76.88M |
|
|
|||||
| Total Current Assets | 154.90M | 84.59M | 105.69M | 58.33M | 76.88M |
| Net Property, Plant & Equipment | 30.79M | 31.50M | 32.28M | 33.08M | 33.89M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.68M | 3.55M | 3.35M | 3.35M | 4.15M |
| Total Assets | 189.36M | 119.64M | 141.32M | 94.76M | 114.92M |
|
|
|||||
| Total Accounts Payable | 2.03M | 2.07M | 3.98M | 2.53M | 4.96M |
| Total Accrued Expenses | 7.35M | 5.03M | 11.57M | 11.97M | 12.37M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.78M | 2.76M | 2.74M | 2.73M | 2.71M |
| Total Finance Division Other Current Liabilities | 25.88M | 31.86M | 34.70M | 963.00K | 861.00K |
| Total Other Current Liabilities | 25.88M | 31.86M | 34.70M | 963.00K | 861.00K |
| Total Current Liabilities | 38.04M | 41.72M | 52.99M | 18.19M | 20.91M |
|
|
|||||
| Total Current Liabilities | 38.04M | 41.72M | 52.99M | 18.19M | 20.91M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 14.87M | 14.96M | 15.05M | 15.13M | 15.21M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.72M | 2.78M | 4.64M | 2.90M | 2.97M |
| Total Liabilities | 55.63M | 59.46M | 72.68M | 36.22M | 39.08M |
|
|
|||||
| Common Stock & APIC | 841.33M | 753.67M | 751.69M | 725.14M | 722.72M |
| Retained Earnings | -707.37M | -693.45M | -683.06M | -666.60M | -646.88M |
| Treasury Stock & Other | -227.00K | -41.00K | 8.00K | 2.00K | -1.00K |
| Total Common Equity | 133.73M | 60.18M | 68.64M | 58.53M | 75.84M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 133.73M | 60.18M | 68.64M | 58.53M | 75.84M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 133.73M | 60.18M | 68.64M | 58.53M | 75.84M |
|
|
|||||